Director
Janssen Pharmaceuticals
Amitava is currently a Director in Clinical Pharmacology & Pharmacometrics, where he supports global drug development programs. He has 13 years of experience in the pharmaceutical industry supporting various therapeutic areas and has previously worked at Merck and Novartis. Amitava has a PhD in Pharmaceutical Sciences from University of Maryland, Baltimore. Amitava’s main research interests include clinical pharmacology, modeling & simulation, pharmacokinetics, and biopharmaceutics. He has interacted with several regulatory agencies like FDA, EMA and PMDA on these topics, as part of project support as well as in workshops and consortia. Amitava has published more than 50 research and review articles, and has 30 podium presentations in national & international conferences, on these topics. Amitava has won several awards including the Novartis VIVA Leading Science award in 2019 for his modeling efforts, an award that celebrates exceptional contribution by scientists across the company’s R&D organization worldwide. Amitava has been involved in several cross-industry consortia such as IMI-OrBiTo and IQ. He is active in AAPS and ASCPT.
Disclosure information not submitted.
Tuesday, January 11, 2022
9:50 AM – 9:55 AM ET
Friday, January 14, 2022
11:15 AM – 12:15 PM ET
.png)